Association of [1 H]-MRS quantified liver fat content with glucose metabolism status

Diabetology & Metabolic Syndrome
Yun-Sheng WangWu Dai

Abstract

Previous literatures have implied that the liver fat deposition plays a crucial role in the development and progression of insulin resistance. In the present study, we aimed to investigate the association of liver fat content (LFC) with glucose metabolism status in the population of newly diagnosed type 2 diabetes mellitus (nT2DM), prediabetes mellitus (PDM) and normal controls (NC), and assessing if the LFC could as an indicator for the prediction of T2DM. A total of 242 subjects (including 141 nT2DM patients, 48 PDM subjects and 53 NC) were enrolled. The levels of LFC were quantified by using the proton magnetic resonance spectroscopy ([1H]-MRS) technique. Clinical and laboratory parameters of study subjects were collected by medical records and biochemical detection. One-way ANOVA or nonparametric test (Kruskal-Wallis) was applied for intergroup comparisons; intergroup comparison was performed in using of Bonferroni multiple-significance-test correction. There were significantly increased LFC levels in nT2DM (14.72% ± 6.37%) than in PDM (9.62% ± 4.41%) and that of NC groups (5.11% ± 3.66%) (all p < 0.001). The prevalence of nonalcoholic fatty liver disease (NAFLD) was also found to be increased in nT2DM (91.48%) than in PDM ...Continue Reading

References

Feb 24, 2001·American Journal of Hypertension·M C LansangJ S Carroll
Jan 13, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·M den BoerJ A Romijn
Sep 2, 2004·American Journal of Physiology. Endocrinology and Metabolism·Lidia S SzczepaniakRobert L Dobbins
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jeffrey D BrowningHelen H Hobbs
Apr 4, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Nathalie C LeiteClaudia R L Cardoso
Aug 12, 2008·Current Clinical Pharmacology·Ton J CleophasBas M van Ouwerkerk
Sep 23, 2009·The Journal of Endocrinology·Yi Lin, Zhongjie Sun
Dec 17, 2009·Topics in Magnetic Resonance Imaging : TMRI·William H PermanIsin Akduman
Feb 3, 2011·Diabetes Technology & Therapeutics·Hua BianXin Gao
Sep 17, 2013·Quantitative Imaging in Medicine and Surgery·Guido LigabueGiovanni Guaraldi
Feb 15, 2014·Clinical Biochemistry·Erdim SertogluTeoman Dogru
Jul 16, 2015·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Ahmed O AlmobarakMohamed H Ahmed
Jan 1, 2015·Nature Reviews. Disease Primers·Ralph A DeFronzoRam Weiss
Dec 17, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fernando BrilKenneth Cusi
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Jan 24, 2018·Diabetes Care·Alessandro MantovaniGiovanni Targher
Jun 29, 2018·Journal of Clinical and Translational Hepatology·Shujing LvShiying Xuan
Sep 25, 2012·Clinical Liver Disease·Puneet Puri, Arun J Sanyal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SPSS
GE SAGE

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.